Metoprolol: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(→‎History: Added patent)
imported>Robert Badgett
Line 5: Line 5:
Metoprolol tartrate was developed by Novartis and received approval in the [[United States]] August 7, 1978.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=LOPRESSOR Drugs@FDA]. U S Food and Drug Administration</ref>
Metoprolol tartrate was developed by Novartis and received approval in the [[United States]] August 7, 1978.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=LOPRESSOR Drugs@FDA]. U S Food and Drug Administration</ref>


Toprol-XL brand of metoprolol succinate was developed by Astrazeneca. Its patent was filed on Sep 28, 1990 and approved on Jan 14, 1992 .<ref>[http://www.google.com/patents?id=shsMAAAAEBAJ Metroprolol succinate]. Google Patents.</ref> It received approval in the [[United States]] on January 10, 1992. According to drugstore.com, 30 days of 100 mg pills costs $52.99 in January, 2009.
Toprol-XL brand of metoprolol succinate was developed by Astrazeneca. Its [[patent]] was filed on Sep 28, 1990 and approved on Jan 14, 1992 .<ref>[http://www.google.com/patents?id=shsMAAAAEBAJ Metroprolol succinate]. Google Patents.</ref> It received approval in the [[United States]] on January 10, 1992. According to drugstore.com, 30 days of 100 mg pills costs $52.99 in January, 2009.


Generic metoprolol succinate was developed by Sandoz and received approval in the [[United States]] on July 31, 2006. According to drugstore.com, 30 days of 100 mg pills costs $25.99 in January, 2009.
Generic metoprolol succinate was developed by Sandoz and received approval in the [[United States]] on July 31, 2006. According to drugstore.com, 30 days of 100 mg pills costs $25.99 in January, 2009.
Astrazenaca and the manufacturer of generic metoprolol succinate have engaged in a lawsuit.<ref name="urlwww.cafc.uscourts.gov">{{cite web |url=http://www.cafc.uscourts.gov/opinions/06-1254.pdf |title=United States Court of Appeals for the Federal Circuit. 2006-1254. IN RE METOPROLOL SUCCINATE PATENT LITIGATION  |author=United States Court of Appeals for the Federal Circuit |authorlink=http://www.cafc.uscourts.gov/ |coauthors= |date= |format=pdf |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-01-11}}</ref>


==Metabolism==
==Metabolism==

Revision as of 15:08, 11 January 2009

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, metoprolol is a adrenergic beta-antagonist that is a "selective adrenergic beta-1-blocking agent with no stimulatory action. It's binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias." It is also used for heart failure.[1]

History

Metoprolol tartrate was developed by Novartis and received approval in the United States August 7, 1978.[2]

Toprol-XL brand of metoprolol succinate was developed by Astrazeneca. Its patent was filed on Sep 28, 1990 and approved on Jan 14, 1992 .[3] It received approval in the United States on January 10, 1992. According to drugstore.com, 30 days of 100 mg pills costs $52.99 in January, 2009.

Generic metoprolol succinate was developed by Sandoz and received approval in the United States on July 31, 2006. According to drugstore.com, 30 days of 100 mg pills costs $25.99 in January, 2009.

Astrazenaca and the manufacturer of generic metoprolol succinate have engaged in a lawsuit.[4]

Metabolism

It is metabolized by cytochrome P-450 2D6 allele and so may have drug interactions[5] and inherited variations in metabolism.[6]

Dosage

For healthy adults, the starting dose is 25 to 100 mg daily in single or divided doses and the maximum dose is 400 to 450 mg/day.

Efficacy

Metoprolol can benefit patients with heart failure.[7]

External links

The most up-to-date information about Metoprolol and other drugs can be found at the following sites.


References

  1. Anonymous (2024), Metoprolol (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Drugs@FDA. U S Food and Drug Administration
  3. Metroprolol succinate. Google Patents.
  4. [States Court of Appeals for the Federal Circuit]. United States Court of Appeals for the Federal Circuit. 2006-1254. IN RE METOPROLOL SUCCINATE PATENT LITIGATION (pdf). Retrieved on 2009-01-11.
  5. Onalan O, Cumurcu BE, Bekar L (May 2008). "Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine". Mayo Clin. Proc. 83 (5): 595–9. PMID 18452693[e]
  6. Nozawa T, Taguchi M, Tahara K, et al (November 2005). "Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol". J. Cardiovasc. Pharmacol. 46 (5): 713–20. PMID 16220080[e]
  7. Waagstein F, Bristow MR, Swedberg K, et al (December 1993). "Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group". Lancet 342 (8885): 1441–6. PMID 7902479[e]